Sanofi Consumer [SANOFICONR] vs Marksans Pharma [MARKSANS] Detailed Stock Comparison
Sanofi Consumer
NSE
Loading...
Marksans Pharma
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Sanofi Consumer wins in 12 metrics, Marksans Pharma wins in 6 metrics, with 0 ties. Sanofi Consumer appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Sanofi Consumer | Marksans Pharma | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 59.52 | 25.55 | Marksans Pharma |
| Price-to-Book Ratio | 46.42 | 3.94 | Marksans Pharma |
| Debt-to-Equity Ratio | 11.01 | 12.93 | Sanofi Consumer |
| PEG Ratio | 6.10 | N/A | N/A |
| EV/EBITDA | 45.67 | 18.78 | Marksans Pharma |
| Profit Margin (TTM) | 27.62% | 14.51% | Sanofi Consumer |
| Operating Margin (TTM) | 30.42% | 14.54% | Sanofi Consumer |
| EBITDA Margin (TTM) | 30.42% | 14.54% | Sanofi Consumer |
| Return on Equity | 66.30% | 16.73% | Sanofi Consumer |
| Return on Assets (TTM) | 41.97% | 9.40% | Sanofi Consumer |
| Free Cash Flow (TTM) | $4.29B | $337.45M | Sanofi Consumer |
| Dividend Yield | 1.08% | 0.62% | Sanofi Consumer |
| 1-Year Return | 5.65% | 8.17% | Marksans Pharma |
| Price-to-Sales Ratio (TTM) | 16.48 | 3.70 | Marksans Pharma |
| Enterprise Value | $117.41B | $94.15B | Sanofi Consumer |
| EV/Revenue Ratio | 16.22 | 3.59 | Marksans Pharma |
| Gross Profit Margin (TTM) | 72.30% | 54.09% | Sanofi Consumer |
| Revenue per Share (TTM) | $314 | $58 | Sanofi Consumer |
| Earnings per Share (Diluted) | $87.04 | $8.39 | Sanofi Consumer |
| Beta (Stock Volatility) | N/A | 1.26 | N/A |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Sanofi Consumer vs Marksans Pharma Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Sanofi Consumer | 0.00% | 6.59% | 1.23% | 4.48% | 9.66% | 5.54% |
| Marksans Pharma | -1.59% | -6.19% | -16.44% | -6.82% | -21.06% | -30.76% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Sanofi Consumer | 5.65% | 5.65% | 5.65% | 5.65% | 5.65% | 5.65% |
| Marksans Pharma | 8.17% | 323.17% | 330.95% | 95.96% | 5,108.64% | 665.42% |
Performance & Financial Health Analysis: Sanofi Consumer vs Marksans Pharma
| Metric | SANOFICONR | MARKSANS |
|---|---|---|
| Market Information | ||
| Market Cap | ₹119.31B | ₹97.14B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 28,486 | 2,019,098 |
| 90 Day Avg. Volume | 18,526 | 1,337,898 |
| Last Close | ₹5,180.70 | ₹210.95 |
| 52 Week Range | ₹4,211.55 - ₹5,894.50 | ₹171.00 - ₹358.70 |
| % from 52W High | -12.11% | -41.19% |
| All-Time High | ₹5,894.50 (Jun 30, 2025) | ₹358.70 (Dec 02, 2024) |
| % from All-Time High | -12.11% | -41.19% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.34% | 0.27% |
| Quarterly Earnings Growth | 1.09% | 0.16% |
| Financial Health | ||
| Profit Margin (TTM) | 0.28% | 0.15% |
| Operating Margin (TTM) | 0.30% | 0.15% |
| Return on Equity (TTM) | 0.66% | 0.17% |
| Debt to Equity (MRQ) | 11.01 | 12.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹111.61 | ₹54.44 |
| Cash per Share (MRQ) | ₹94.19 | ₹15.58 |
| Operating Cash Flow (TTM) | ₹2.25B | ₹2.07B |
| Levered Free Cash Flow (TTM) | ₹1.81B | ₹-725,402,496 |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.08% | 0.62% |
| Last 12-Month Dividend | ₹55.00 | ₹1.40 |
Valuation & Enterprise Metrics Analysis: Sanofi Consumer vs Marksans Pharma
| Metric | SANOFICONR | MARKSANS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 59.52 | 25.55 |
| Forward P/E | 43.03 | 15.40 |
| PEG Ratio | 6.10 | N/A |
| Price to Sales (TTM) | 16.48 | 3.70 |
| Price to Book (MRQ) | 46.42 | 3.94 |
| Market Capitalization | ||
| Market Capitalization | ₹119.31B | ₹97.14B |
| Enterprise Value | ₹117.41B | ₹94.15B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 16.22 | 3.59 |
| Enterprise to EBITDA | 45.67 | 18.78 |
| Risk & Other Metrics | ||
| Beta | N/A | 1.26 |
| Book Value per Share (MRQ) | ₹111.61 | ₹54.44 |
Financial Statements Comparison: Sanofi Consumer vs Marksans Pharma
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SANOFICONR | MARKSANS |
|---|---|---|
| Revenue/Sales | ₹1.73B | ₹7.08B |
| Cost of Goods Sold | ₹388.00M | ₹3.25B |
| Gross Profit | ₹1.34B | ₹3.83B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹620.00M | ₹1.03B |
| EBITDA | ₹692.00M | ₹1.42B |
| Pre-Tax Income | ₹668.00M | ₹1.16B |
| Income Tax | ₹168.00M | ₹253.68M |
| Net Income (Profit) | ₹500.00M | ₹907.25M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SANOFICONR | MARKSANS |
|---|---|---|
| Cash & Equivalents | ₹3.27B | ₹4.96B |
| Total Current Assets | ₹3.92B | ₹22.04B |
| Total Current Liabilities | ₹1.31B | ₹4.77B |
| Long-Term Debt | ₹166.00M | ₹2.63B |
| Total Shareholders Equity | ₹2.73B | ₹24.89B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | ₹272.00M | ₹8.86B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SANOFICONR | MARKSANS |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SANOFICONR | MARKSANS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 28,486 | 2,019,098 |
| Average Daily Volume (90 Day) | 18,526 | 1,337,898 |
| Shares Outstanding | 23.03M | 453.16M |
| Float Shares | 6.57M | 214.46M |
| % Held by Insiders | 0.71% | 0.46% |
| % Held by Institutions | 0.25% | 0.17% |
Dividend Analysis & Yield Comparison: Sanofi Consumer vs Marksans Pharma
| Metric | SANOFICONR | MARKSANS |
|---|---|---|
| Last 12-Month Dividend | ₹55.00 | ₹1.40 |
| Last 12-Month Dividend Yield | 1.08% | 0.62% |
| 3-Year Avg Annual Dividend | ₹18.33 | ₹0.72 |
| 3-Year Avg Dividend Yield | 1.11% | 0.40% |
| 3-Year Total Dividends | ₹55.00 | ₹2.15 |
| Ex-Dividend Date | Apr 17, 2025 | Aug 01, 2025 |